David L. Cooper

David L. Cooper

Auto-generated profile, based on publicly available information

David L. Cooper

Novo Nordisk Inc., Plainsboro, NJ, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2017 in Haemophilia
Verified
Journal Article
Open access
PDF file
MWM. Witkop
M. Witkop
ANA. Neff
A. Neff
TBT. W. Buckner
T. W. Buckner
MWM. Wang
M. Wang
KBK. Batt
K. Batt
CKC. L. Kempton
C. L. Kempton
Introduction: Haemophilia is characterized by frequent haemarthrosis, leading to acute/chronic joint pain.Aim: To assess self‐reported prevalence, description and management of pain in adult males with mild‐to‐severe haemophilia and history of joint pain/bleeding.Methods: Participants completed a pain survey and five patient‐reported outcome instruments assessing pain, functional impairment and health‐related quality of life (HRQoL).Results: Of 381 participants enrolled, median age was 34 years; 77% had haemophilia A, 71% had severe disease and 65% were overweight/obese. Many (56%) were not receiving routine infusions; 30% never received routine infusions. During the prior 6 months, 20% experienced acute pain, 34% chronic pain and 32% both acute/chronic pain. Subjects with both acute/chronic pain (vs. none, acute or chronic) were more likely to be depressed (30% vs. 0–15%), obese (35% vs. 20–29%) and have lower HRQoL (mean EQ‐5D visual analog scale, 69 vs. 83–86) and function (median overall Hemophilia Activities List, 60 vs. 88–99). Most common analgesics used for acute/chronic pain during the prior 6 months were acetaminophen (62%/55%) and non‐steroidal anti‐inflammatory drugs (34%/49%); most common non‐pharmacologic strategies were ice (65%/33%) and rest (51%/33%). Hydrocodone‐acetaminophen was the most common opioid for both acute/chronic pain (30%); other long‐acting opioids were infrequently used specifically for chronic but not acute pain (morphine, 7%; methadone, 6%; fentanyl patch, 2%).Conclusion: Patients with chronic pain, particularly those with both acute/chronic pain, frequently experience psychological issues, functional disability and reduced HRQoL. Treatment strategies for acute pain (e.g. routine infusions to prevent bleeding) and for chronic pain (e.g. long‐acting opioids) may be underused.

1 October 2017 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
MWMichael Wang
Michael Wang
KBKatharine Batt
Katharine Batt
CKCraig Kessler
Craig Kessler
ANAnne Neff
Anne Neff
NINeeraj N Iyer
Neeraj N Iyer
CKChristine L Kempton
Christine L Kempton
Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study Michael Wang,1 Katharine Batt,2 Craig Kessler,3 Anne Neff,4 Neeraj N Iyer,5 David L Cooper,5 Christine L Kempton6 1Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora, CO, 2Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Medicine and Pathology, Division of Hematology/Oncology, Georgetown University Hospital, Washington, DC, 4Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, 5Novo Nordisk Inc., Clinical, Medical, and Regulatory Affairs, Plainsboro, NJ, 6Departments of Pediatrics and Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA Background: The Pain, Functional Impairment, and Quality of Life study was an observational, cross-sectional assessment of the impact of pain on functional impairment and quality of life in adult people with hemophilia (PWH) of any severity in the USA who experience joint pain and/or bleeding.Objective: To assess internal consistency (IC) and item-total correlation (ITC) of assessment tools used in the Pain, Functional Impairment, and Quality of Life study.Methods: Participants completed 5 patient-reported outcome instruments (­EQ-5D-5L with visual analog scale, Brief Pain Inventory v2 Short Form [BPI], International Physical Activity Questionnaire [IPAQ], Short Form 36 Health Survey v2 [SF-36v2], and Hemophilia Activities List [HAL]) and underwent an optional physiotherapist-administered musculoskeletal exam (Hemophilia Joint Health Score v2.1) during routine visits. Reliability assessment included IC and ITC of each instrument.Results: A total of 381 adult PWH (median age, 34 years) were enrolled. Participants were predominantly white/non-Hispanic (69.2%); 75% had congenital hemophilia A, and 70.5% had severe hemophilia. A total of 310 subjects reported bleeding within the past 6 months (mean [SD] number of bleeds, 7.1 [13.00]). IC was generally high across the instruments employed (Cronbach’s alpha 0.79–0.98) with the exception of HAL use of transportation (0.58) and IPAQ total physical activity (0.51). ITC was high (Pearson’s product-moment correlation coefficient >0.20) for all items except the “vigorous intensity activities” item of IPAQ, which was applicable to less than one-third of participants. The ITCs were generally highest in domains/scores that measured the functional consequences of hemophilic arthropathy on mobility and pain.Conclusion: The demonstrated reliability (IC/ITC) of the patient-reported outcome instruments and Hemophilia Joint Health Score v2.1 support a role for these instruments in evaluating adult PWH in US clinical and research settings. Keywords: hemophilia, pain, functional impairment, quality of life, patient-reported outcome, joint health

2 March 2018 in European Journal of Haematology
Verified
Journal Article
Open access
PDF file
TBTyler W. Buckner
Tyler W. Buckner
KBKatharine Batt
Katharine Batt
DQDoris Quon
Doris Quon
MWMichelle Witkop
Michelle Witkop
MRMichael Recht
Michael Recht
CKChristine L. Kempton
Christine L. Kempton
Introduction: Pain, functional impairment, anxiety, and depression associated with joint disease may affect health‐related quality of life (HRQoL) in people with hemophilia.Objective: To report detailed patient‐reported outcomes (PRO) assessments related to HRQoL in participants in the Pain, Functional Impairment, and Quality of Life (P‐FiQ) study.Methods: Pain and HRQoL were assessed via PRO instruments in US adult males with hemophilia A or B and a history of joint pain or bleeding. PRO instruments included EQ‐5D‐5L with visual analog scale, Brief Pain Inventory v2 Short Form, SF‐36v2, and Hemophilia Activities List. Instrument domain and item responses were described.Results: Responses were collected from 381 adult males with a median age of 34 years. Pain was observed across instruments and affected daily activities and quality of life. Respondents reported functional impairment that limited the kind of work and activities they participated in, with activities involving the lower extremities being most affected. A high prevalence of mental health disorders was identified across instruments.Conclusions: Pain and HRQoL were evaluated using multiple PRO instruments, which vary in timescales of assessment and levels of detail. More consistent clinical assessments and patient dialog regarding pain and aspects of HRQoL may help drive improved outcomes.


1 October 2018 in Journal of Blood Medicine
Verified
Journal Article
Open access
PDF file
DNDiane J Nugent
Diane J Nugent
ARAlicia A Romano
Alicia A Romano
SSShreya Sabharwal
Shreya Sabharwal
DCDavid L Cooper
David L Cooper
Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review Diane J Nugent,1 Alicia A Romano,2 Shreya Sabharwal,3 David L Cooper3 1Center for Inherited Bleeding Disorders, Children’s Hospital of Orange County, Orange, CA, USA; 2Department of Pediatrics, New York Medical College, Valhalla, NY, USA; 3Medical and Regulatory Affairs, Novo Nordisk Inc, Plainsboro, NJ, USA Background: Noonan syndrome (NS) is an autosomal dominant genetic condition that has a number of clinical features, including bleeding diathesis and a number of hematological abnormalities including clotting factor deficiencies, von Willebrand disease and abnormal platelet count/function. Methods: We evaluated the frequency/types of bleeding disorders, and associated hematological laboratory findings, in patients with NS, using published data from 1965 to 2014. Results: Of 45 studies identified, 31 included data for 428 patients with NS. Of these patients, 43% had reported bleeding, 26% had no reported bleeding and no bleed data was reported for 31%. Most patients (90%) had bleeding-related laboratory test abnormalities, but only 194 (45%) had a confirmed diagnosis of a specific bleeding disorder. Abnormal laboratory tests included: prolonged prothrombin time, activated partial thromboplastin time, and other platelet-related disorders. Of the 194 patients with a confirmed diagnosis of a specific bleeding disorder, 153 (79%) had single clotting factor deficiencies, von Willebrand disease or platelet-related disorders, and 41 (21%) had multiple deficiencies including platelet-related disorders. Conclusion: As patients with NS can experience multiple bleeding disorders, including abnormal platelet function, clinical evaluations should be performed at diagnosis, after diagnosis, before any surgery is undertaken, and if patients become symptomatic. Keywords: bleeding disorders, children, laboratory test abnormalities, Noonan syndrome, screening, surgical procedures

5 March 2018 in European Journal of Haematology
Verified
Journal Article
Open access
PDF file
TBTyler W. Buckner
Tyler W. Buckner
MWMichelle Witkop
Michelle Witkop
CGChristine Guelcher
Christine Guelcher
RSRobert Sidonio
Robert Sidonio
CKCraig M. Kessler
Craig M. Kessler
DCDavid L. Cooper
David L. Cooper
Introduction: Health‐related quality of life (HRQoL) is impaired in patients with hemophilia; however, the impact in mild/moderate hemophilia B and affected women is not well characterized.Objective: To evaluate factors that affect HRQoL in adults with hemophilia B and caregivers of affected children.Methods: US adult patients and caregivers of affected children completed distinct ~1‐hour online surveys including patient‐reported outcome instruments.Results: In total, 299 adult patients and 150 caregivers participated. Adults with moderate hemophilia reported poorer health status (median EQ‐5D‐5L index score, 0.63) than those with mild (0.73) or severe (0.74) hemophilia. Women reported greater pain severity than men on the Brief Pain Inventory v2 Short Form (median, 7.00 vs 5.00). Based on the Patient Health Questionnaire, mild or worse depression was observed in >50% of adult respondents, and depression was reported more often in those with moderate and severe hemophilia vs those with mild hemophilia. Most caregivers reported at least mild depression.Conclusion: Pain, functional impairment, and depression/anxiety are present at higher‐than‐expected levels in individuals with hemophilia B. The large proportion of individuals with mild/moderate hemophilia and women with reduced health status suggests significant unmet needs in this population.